Ex-CytoDyn CEO Sues In Del. Chancery Court For Legal Fees

By Rose Krebs · January 20, 2023, 4:33 PM EST

CytoDyn Inc.'s former CEO has filed a complaint asking the Delaware Chancery Court to order the biotech company to cover legal costs he has incurred in connection with "governmental investigations" that...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Rose

April 08, 2025
Longtime Cooley Life Sciences Ace Jumps To Wilson Sonsini
March 31, 2025
Pierson Ferdinand Adds Taylor English Health Pro In Atlanta
February 25, 2025
Masimo Aims To DQ Hueston Hennigan As Ex-CEO's Counsel
January 13, 2025
Proskauer Faces Revived DQ Bid In NJ Hospital Antitrust Fight
January 06, 2025
Sheppard Mullin Hires University Of Calif. Health Counsel
November 19, 2024
McDermott Adds IP Pro From Gibson Dunn In Los Angeles
November 12, 2024
Thompson Coburn Hit With Suit Over Healthcare Data Breach
November 05, 2024
McDermott Lands Pharma IP Attorney From DLA Piper In SF
September 24, 2024
Firms Allowed To Exit IP Case After Gaining Philips' Consent
September 03, 2024
Ex-Tesla Atty Joins Cell Therapy Business As General Counsel